Hyperfine (HYPR) Research & Development (2021 - 2026)
Hyperfine (HYPR) posted Research & Development of $3.8 million for Q1 2026, up 0.52% on a QoQ basis from $3.8 million in Q4 2025, and up 51.38% year-over-year from $2.5 million in Q1 2025.
Hyperfine (HYPR) Research & Development (2021 - 2026) Analysis & Trends
Hyperfine's Research & Development history runs 6 years deep, the most recent figure standing at $3.8 million for Q1 2026.
- Quarterly Research & Development rose 51.38% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.8 million (down 19.13% YoY) and the FY2025 annual result came in at $17.5 million, down 22.44% from the prior year.
- Research & Development was $3.8 million for Q1 2026 at Hyperfine, up from $3.8 million in the prior quarter.
- Across five years, Research & Development topped out at $14.9 million in Q4 2023 and bottomed at $2.0 million in Q1 2024.
- A 5-year average of $4.8 million and a median of $4.2 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development soared 306.55% — and 2024, when it sank 65.78%.
- Hyperfine's Research & Development stood at $5.2 million in 2022, then jumped by 185.84% to $14.9 million in 2023, then sank by 65.78% to $5.1 million in 2024, then decreased by 25.07% to $3.8 million in 2025, then increased by 0.52% to $3.8 million in 2026.
- Business Quant data shows HYPR's Research & Development at $3.8 million in Q1 2026, $3.8 million in Q4 2025, and $2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | 3.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.85 Mn |
| Dec 31, 2025 | 3.83 Mn |
| Sep 30, 2025 | 2.57 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Dec 31, 2024 | 5.11 Mn |
| Sep 30, 2024 | 5.87 Mn |
| Jun 30, 2024 | 2.27 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 14.92 Mn |
| Sep 30, 2023 | 5.74 Mn |
| Jun 30, 2023 | 5.33 Mn |
| Mar 31, 2023 | 5.46 Mn |
| Dec 31, 2022 | 5.22 Mn |
| Sep 30, 2022 | 3.43 Mn |
| Jun 30, 2022 | 7.27 Mn |
| Mar 31, 2022 | 4.16 Mn |
| Dec 31, 2021 | -6.59 Mn |
| Sep 30, 2021 | 2.79 Mn |
| Jun 30, 2021 | 1.79 Mn |